United States: Blog Series Part 3: CMS Proposed Rule On Policy And Technical Changes To The Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, And Medicaid Managed Care Programs For Years 2020 And 2021

Medicare Advantage and Part D Preclusion List

The proposed rule issued November 1, 2018 (the "Proposed Rule") by the Centers for Medicare and Medicaid Services ("CMS") includes a number of regulatory changes to the manner in which providers are to be included on CMS' Medicare Advantage and Part D "Preclusion List", providers' appeal rights prior to such inclusion, the timeframes that providers must remain on the list, and the financial impact to beneficiaries and claimants who receive and provide items and services furnished or prescribed by a precluded provider.

Background; The April 2018 Final Rule

Prior to 2018, many Part D prescribers, Medicare Advantage ("MA") providers, MA Organizations ("MAOs") and Part D Plans ("PDPs") had complained about the enrollment burden imposed by CMS' preexisting rules, which required that (i) for a prescription to be eligible for coverage under Part D, the prescriber must be enrolled in the Medicare fee-for-service program; and (ii) providers who furnish items and services to a beneficiary who receives his or her Medicare benefit through an MAO must be enrolled in the Medicare fee-for-service program. MAOs and PDPs had also complained about the rules' impact on their ability to maintain adequate provider networks. Nearly 500,000 Part D prescribers and 120,000 MA providers remain unenrolled in the Medicare fee-for-service program.

Accordingly, in its April 16, 2018 Final Rule (the "Final Rule"), CMS removed those regulatory requirements, opting to protect MA and Part D program integrity not via the enrollment processes, but rather by promulgating rules that would (1) have CMS publish a "preclusion list" that will identify "demonstrably problematic" providers and prescribers, and (2) require MAOs and PDPs to reject or deny payments for MA services and items and Part D drugs furnished or prescribed by precluded providers and prescribers, respectively.

The Proposed Rule

Appeal Processes for Individuals and Entities Notified of Inclusion on the Preclusion List

Although the Final Rule established an appeals process for providers notified of CMS' decision to place them on the preclusion list, the Proposed Rule seeks to abbreviate the timeframe for that process with respect to providers to be placed on the preclusion list due to the revocation of their Medicare enrollment. Under the current process, a precluded provider may commence the appeal of notice of being added to the preclusion list after the resolution of an appeal of his or her Medicare revocation – a staggered process that requires the MAO or PDP to pay for items and services ordered or prescribed by a precluded provider for up to nine (9) months after the provider's entry on the preclusion list. To shorten this timeframe, the Proposed Rule would consolidate these appeals processes, such that they run concurrently and not consecutively, and would also allow a provider to request a joint reconsideration of notice of both enrollment revocation and inclusion on the preclusion list.

Effective Dates

The proposed changes related to the abbreviation and consolidation of the appeals process, as described above, would take effect 60 days after publication of a final rule. The remaining proposed rules, as described below, would take effect on January 1, 2020.

Timing of Addition to Preclusion List

Once a provider is notified that CMS intends to include the provider on the preclusion list, the provider has 60 days to file a reconsideration request. Under the Proposed Rule, a provider would be placed on the preclusion list either (i) upon the expiration of that 60-day period, if the provider does not file a reconsideration request, or (ii) upon the date on which CMS denies the provider's reconsideration, if requested and denied.

However, with respect to providers and prescribers who are excluded from Federal health care program participation by the Department of Health and Human Services Office of the Inspector General (“OIG"), CMS proposes to include such providers and prescribers on the preclusion list, effective as of the dates of their exclusion, even if they request that CMS reconsider their inclusion on the preclusion list.

Claims Denials and Beneficiary Notification

In the Final Rule, CMS imposed a 90-day wait period between (i) CMS' publication of its first preclusion list, and (ii) the first date on which an MAO or PDP could deny claims for services or items ordered or prescribed by a precluded provider. CMS designed the 90-day period to allow MAOs and PDPs to intake the preclusion list, to notify beneficiaries of provider and prescriber preclusions, and to work with affected beneficiaries to transition them to new providers and prescribers. However, under the Final Rule, no such time period applied to subsequent additions to the preclusion list, i.e., an MAO or PDP could deny claims submitted for services and items ordered and prescribed by a provider or prescriber added to the initial preclusion list, effective the first day of that provider's inclusion on the list. In preamble commentary to the Proposed Rule, CMS stated that it is concerned with this rule's impact on beneficiary access to care. Accordingly, the Proposed Rule would apply the 90-day wait period with respect to claims submitted for services and items ordered and prescribed by a provider added as part of an update to the preclusion list. Although this proposal would be effective January 1, 2020, CMS recommended that MAOs and PDPs adopt this policy on January 1, 2019 (i.e., the effective date of the Final Rule).

Beneficiary Appeals

The Proposed Rule would add a regulatory provision specifically stating that a beneficiary could not appeal a payment denial based upon a provider's or prescriber's inclusion on the preclusion list.

Time on the List: Felony Convictions and OIG Exclusions

Under the Final Rule, unenrolled prescribers and providers who are on the preclusion list stay on the preclusion list for the same length of time as the reenrollment bar that CMS could have imposed, had they been enrolled and then revoked. However, CMS believes that providers and prescribers convicted of a felony should remain on the preclusion list for longer periods of time, if appropriate. Therefore, the Proposed Rule would require providers and prescribers included on the preclusion list because of a felony conviction to stay on the list for a 10-year period running from the date of conviction, unless CMS determines a shorter length of time is warranted. This is a significant consideration for providers faced with criminal proceedings and the choice to plea to a lesser (but felony) offense. Similarly, to the extent that the OIG excludes a provider or prescriber from Federal health care program participation for a period of time longer than the reenrollment bar, CMS proposes to keep such a provider or prescriber on the preclusion list until the OIG reinstates the provider.

Beneficiary Liability

The Proposed Rule would add a regulatory provision requiring an MAO's contract with CMS to specifically state that an MA enrollee must not have any financial liability for services or items furnished to the enrollee by an MA-contracted individual or entity on the preclusion list. CMS acknowledges that this proposal would only extend to MA-contracted providers (and would not extend to out-of-network providers).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
31 Jan 2019, Other, Los Angeles, United States

Invites you to join us for a private cooking class hosted by Parties that Cook!

31 Jan 2019, Conference, Los Angeles, United States

The Southern California Association of Corporate Counsel's In-House Counsel Conference

6 Feb 2019, Other, Los Angeles, United States

Please join Sheppard Mullin for cocktails & hors d'oeuvres during The Wind Power Finance & Investment Summit 2019

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions